J
Juvisé Pharmaceuticals
International pharmaceutical company that specializes in acquiring, manufacturing and commercializing specialty products
About Juvisé Pharmaceuticals
Juvise Pharmaceuticals is a multinational pharmaceutical company that specializes in providing ethical pharmaceutical products across various medical fields including oncology, cardiology, neurology, psychiatry, and rheumatology. The company serves a diverse range of clients, including healthcare providers, hospitals, and medical professionals, primarily in the international market. Juvise Pharmaceuticals operates with a unique business model that emphasizes integration and reliability, ensuring high-quality standards in all its offerings. The company generates revenue through the sale of its high-value products such as Sintrom, Digoxin, Entumin, Insidon, Extovyl, and Lumirelax. These products are designed to treat a variety of conditions including breast cancer, prostate cancer, thromboembolic heart diseases, deep vein thrombosis, pulmonary embolism, high blood pressure, schizophrenia, bipolar disorders, anxiety disorders, chronic depression, vertigo, and muscle contractures.
Source: Dealroom company dataAt a glance
- Outcome tier
- Thoroughbred$100M+ revenue
News
Open roles
Juvisé Pharmaceuticals in the Villeurbanne ecosystem
The Juvisé Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Octalfa
ACG Management
Series B and later2 investors entered at this stage
Societe Generale
Hayfin Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Juvisé Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Juvisé Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

